First, we have validated that the levels of pmTOR and p4E-BP1 were significantly decreased (by 70% and 72% for pmTOR and p4E-BP1, respectively) in rapamycin-treated nasal polyps, confirming that rapamycin functioned as a negative regulator of the mTOR pathway. This evidence concerns the gene MTOR and nasal cavity polyp.